• Proceedings of the Korean Society for Noise and Vibration Engineering Conference
• /
• 2008.04a
• /
• pp.934-938
• /
• 2008

To customize individual characteristics of HRTF, a spherical model has been used for structural modeling technique. A pseudo-code of prolate spheroidal HRTF caused by incident acoustic point source is already developed, and it can be used a head shadow filter for structural modeling of HRTF. In this research, to see the necessity and efficiency of spheroidal head modeling, ITD optimization is performed on CIPIC HRTF database. From given cost function, ITD-optimized spheroidal head model, whose ITD information is the most matched version of measured ITD information, is found by varying head parameters subject by subject. By comparing results of ITD-optimized spheroids and ITD-optimized spheres, we concluded that a spherical head model is more efficient way of generating head shadow effect than a spheroidal head model does.

• Water for future
• /
• v.19 no.1
• /
• pp.57-63
• /
• 1986

The synthetic unit hydrograph is commonly used for the derivation of a design hydregraph. The existing Snyder's equation for the syntheses of unit hydrograph was found to give relatively a flat hydrograph in comparison with observed hydrograph and a revision is required. HEC-1 model is used to simulated observed hydrograhp in the South Han River basin and results are used as an input for the regression. The basin is subdivided into small drainage areas and the synthesized hydrograph is routed through channels. After the calculated hydrographs are compared with observed one, the synthesized hydrograph of each subbasisn is revised and the new snyder's equation is derived . The revised equation gives rapid increase of discharge in rising limb and larger peak.

• The Korean Journal of Nuclear Medicine
• /
• v.30 no.1
• /
• pp.77-85
• /
• 1996

Radioiodine($^{131}I$) has been used for the treatment of Graves' hyperthyroidism since the late 1940's and is now generally regarded as the treatment of choice for Graves' hyperthyroidism who does not remit following a course of antithyroid drugs. But for the dose given, several different protocols have been described by different centers, each attempting to reduce the incidence of long-term hypothyroidism while maintaining an acceptable rate control of Graves' hyperthyroidism. Our goals were to evaluate effective half-life and predict absorbed dose in Graves' hyperthyroidism patients, therefore, to calculate and readminister radioiodine activity needed to achieve aimed radiation dose. Our data showed that the mean effective $^{131}I$ half-life for Graves' disease is 5.3 days(S.D=0.88) and mean biologic half-life is 21 days, range 9.5-67.2 days. The mean admininistered activity and the mean values of absorbed doses were 532 MBq(S.D.=254), 112 Gy (S.D.=50.9), respectively. The mean activity needed to achieve aimed radiation dose were 51MBq and marked differences of $^{131}I$ thyroidal uptake between tracer and therapy ocurred in our study. We are sure that the dose calculation method that uses 5 days thyroidal $^{131}I$ uptake measurements after tracer and therapy dose, provides sufficient data about the effective half-life and absorbed dose of $^{131}I$ in the thyroid and predict the effectiveness of $^{131}I$ treatment in Graves' hyperthyroidism.